Atlas Trials

Comparative Bioavailability Study of Metformin/Sitagliptin 850 mg/50 mg Tablets in Healthy Male and Female Volunteers

Clinical trial NCT05549570 · COMPLETED

Trial details

NCT number
NCT05549570
Sponsor
Galenicum Health
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
BioequivalenceDiabetes Mellitus, Type 2
Start date
2017-10-22
Primary completion
2017-11-01
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.